semaglutide and cancer Ozempic is facing a $2 billion lawsuit the thyroid headline is actually the least of Novo Nordisk's problems. Over 3,500 people have filed claims in federal court. The cases getting GLP-1 use linked to better

Salameh TS, Rhea EM, Talbot K, et al

I liked how easy they were to heat up in the microwave, and the flavors were good (hats off to the Teriyaki sauce)

Compounded versions were often more budget-friendly, and the shift to brand-name GLP-1 medications could mean higher out-of-pocket costs

Then, earlier this year, the startup signed a partnership and license agreement with Novo focused on developing and marketing an oral, small-molecule treatment for obesity

Based on its class, interactions are likely with certain diabetes medications (particularly insulin and sulfonylureas, where there is a hypoglycaemia risk), and gastric emptying effects may alter the absorption of some oral medicines

This weight loss directly addresses one of the primary causes of sleep apnea